Aim: To examine anti-inflammatory effect of statins on outcomes of acute coronary syndrome (ACS).
Material And Methods: The trial included 211 ACS patients without ST elevation at ECG. The patients were followed up for 180 days. The anti-inflammatory action was studied for 30 days. The patients were divided into two groups by the treatment: simvastatin 10 mg + aspirin 325 mg (104 patients, group 1) and simvastatin 40 mg + aspirin 325 mg (107 patients, group 2) for 30 days.
Results: Simvastatin in maximal dose lowed LDLP cholesterol from 101 +/- 9.8 to 72 +/- 3.3 mg/dl, in a minimal dose--from 104 +/- 11.3 to 81 +/- 2.1 mg/dl (p < 0.05). Only maximal dose simvastatin produced a significant reduction of C-reactive protein (CRP) to the disease day 14. The integral index including all cases of cardiovascular death +acute myocardial infarction+progressive angina+rehospitalization was 70 scores for group 1 and 137 for group 2 (p = 0.047).
Conclusion: Use of simvastatin in ACS patients, initially normal level of LDLP cholesterol and elevated level of CRP produced a dose-dependent effect, alleviated inflammation and improved the disease course.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Dyslipidemias in multiple sclerosis.
Mult Scler Relat Disord
November 2024
Departments of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, NY, USA; Neurology, University at Buffalo, The State University of New York, Buffalo, NY, USA. Electronic address:
Purpose: To investigate the frequency of dyslipidemia phenotypes in multiple sclerosis and to assess the associations with lipoprotein particle size distributions.
Methods: This cross-sectional study included 203 healthy controls (HC), 221 relapsing-remitting MS (RRMS), and 126 progressive MS (PMS). A lipid profile with total cholesterol, high-density lipoprotein cholesterol (HDL-C), triglycerides, and apolipoprotein B levels were measured.
High LDL Particle and APOB Concentrations in Patients With Adrenal Cortical Adenomas.
J Clin Endocrinol Metab
December 2024
Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.
Context: Patients with nonfunctioning adenomas (NFAs), adenomas with mild autonomous cortisol secretion (MACS) and Cushing syndrome (CS) demonstrate an increased cardiovascular risk.
Objective: This work aimed to determine the extent of lipoprotein abnormalities in NFA, MACS, and CS.
Methods: We conducted a single-center, cross-sectional study of patients with NFA (n = 167), MACS (n = 213), CS (n = 142), and referent individuals (n = 202) between January 2015 and July 2022.
Low-density lipoprotein particle profiles compared with standard lipids measurements in the association with asymptomatic intracranial artery stenosis.
Sci Rep
May 2024
NCD Epidemiology Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan.
Article Synopsis
- The Shiga Epidemiological Study of Subclinical Atherosclerosis, conducted in Japan from 2006 to 2008, involved 740 men who were analyzed for lipid profiles and assessed for intracranial artery stenosis (ICAS) through MRI from 2012 to 2015.
- Of the participants, 205 (28.8%) had ICAS, and 144 (20.3%) showed discordance between LDL cholesterol (LDL-c) and LDL particle number (LDL-p) levels.
- The study found that individuals with low LDL-c but high LDL-p had the highest risk of ICAS, indicating that assessing both LDL-c and LDL-p may better identify those at risk for arterial issues.
Background: 2025 is going to be the 100th anniversary of the first historical description of Turner syndrome - complex of genomic abnormalities, congenital gonadal disruption and hypergonadotropic hypogonadism. Total estrogenic deficiency triggers development of age-related comorbidities. There is no doubt that personalized search for replicative markers of cellular aging among females with Turner syndrome is needed.
View Article and Find Full Text PDFDiscordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia.
J Clin Lipidol
December 2023
Stravitz-Sanyal Liver Institute, Virginia Commonwealth University, Richmond, Virginia (Drs Sanyal and Siddiqui).
Nonalcoholic fatty liver disease (NAFLD) is associated with atherogenic dyslipidemia and an increased risk of cardiovascular events. Previous studies have suggested an inverse relationship between NAFLD severity and lipoprotein(a) [Lp(a)] level, but contemporary data from the U.S.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!